20223JC48-3 (methyl 4'-methyl-5-(7-nitrobenzo[c][1,2,5]oxadiazol-4-yl)-[1,1'-biphenyl]-3-carboxylate): a novel MYC/MAX dimerization inhibitor reduces prostate cancer growth.
Cancer gene therapy.29(11):1550-1557[DOI] 10.1038/s41417-022-00455-4.[PMID] 35440696.